Table 5.
siRNA | % enhancement of chemosensitivity | ||
---|---|---|---|
|
|||
Doxorubicin | Paclitaxel | Cisplatin | |
ABCG2+ABCB1 1 nM (each) | 43% | 49% | 50% |
ABCG2 1 nM | 14% | 17% | 16% |
ABCB1 1 nM | 18% | 26% | 10% |
Abbreviation: siRNA, small interfering RNA.
siRNA | % enhancement of chemosensitivity | ||
---|---|---|---|
|
|||
Doxorubicin | Paclitaxel | Cisplatin | |
ABCG2+ABCB1 1 nM (each) | 43% | 49% | 50% |
ABCG2 1 nM | 14% | 17% | 16% |
ABCB1 1 nM | 18% | 26% | 10% |
Abbreviation: siRNA, small interfering RNA.